8-K/A

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 8-K/A

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

Date of Report (Date of earliest event reported): March 30, 2017

PROVIDENT FINANCIAL SERVICES, INC.

(Exact Name of Registrant as Specified in its Charter)

Delaware	001-31566	42-1547151
(State or Other Jurisdiction of Incorporation)	(Commission File No.)	(I.R.S. Employer Identification No.)

239 Washington Street, Jersey City, New Jersey	07302
(Address of Principal Executive Offices)	(Zip Code)

Registrant’s telephone number, including area code:     (732) 590-9200

Not Applicable

(Former Name or Former Address, if Changed Since Last Report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

[ ]	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
[ ]	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
[ ]	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
[ ]	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Explanatory Note: This Form 8-K/A is being filed solely to correct a transposition contained on the schedule entitled “Comparative Balance Sheets” as included in Exhibit 99.1 to the Form 8-K as filed on March 28, 2017. No additional changes to the Form 8-K or the exhibit thereto as originally filed have been made.

Item 7.01 Regulation FD Disclosure.

Provident Financial Services, Inc. (the “Company”) is furnishing presentation materials that will be used at various investor conferences during the first and second quarters of 2017, including the Sandler O’Neill & Partners, L.P. investor meetings to be held between March 28 and March 31, 2017 in California. The Company is not undertaking to update the presentation. A copy of the presentation materials is attached as Exhibit 99.1 to this report and is being furnished to the SEC and shall not be deemed “filed” for any purpose.

Item 9.01.Financial Statements and Exhibits

(a) Financial Statements of Business Acquired. Not applicable.

(b) Pro Forma Financial Information. Not applicable.

(c) Shell Company Transactions. Not applicable.

(d) Exhibits.

Exhibit No.Description

99.1 Investor presentation materials to be utilized by the Company at various investor conferences during the first and second quarters of 2017.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.

		PROVIDENT FINANCIAL SERVICES, INC.
DATE: March 30, 2017	By:	/s/ John Kuntz
		John Kuntz
		Executive Vice President, General Counsel & Corporate Secretary

EXHIBIT INDEX

Exhibit No.Description

99.1 Investor presentation materials to be utilized by the Company at various investor conferences during the first and second quarters of 2017.

EX-99.1

Investor Roadshow March 28 thru March 31, 2017

Forward Looking Statements Certain statements contained herein are "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Such forward-looking statements may be identified by reference to a future period or periods, or by the use of forward-looking terminology, such as "may," "will," "believe," "expect," "estimate," "anticipate," "continue," or similar terms or variations on those terms, or the negative of those terms. Forward- looking statements are subject to numerous risks and uncertainties, including, but not limited to, those related to the economic environment, particularly in the market areas in which Provident Financial Services, Inc. (the “Company”) operates, competitive products and pricing, fiscal and monetary policies of the U.S. Government, changes in government regulations affecting financial institutions, including regulatory fees and capital requirements, changes in prevailing interest rates, acquisitions and the integration of acquired businesses, credit risk management, asset-liability management, the financial and securities markets and the availability of and costs associated with sources of liquidity. The Company cautions readers not to place undue reliance on any such forward-looking statements, which speak only as of the date made. The Company also advises readers that the factors listed above could affect the Company's financial performance and could cause the Company's actual results for future periods to differ materially from any opinions or statements expressed with respect to future periods in any current statements. The Company does not have any obligation to update any forward- looking statements to reflect events or circumstances after the date of this statement. A detailed discussion of factors that could affect our results is included in our SEC filings, including the “Risk Factors” section of our Annual Report on Form 10-K for the year ended December 31, 2016.

5 -YEAR COMPARATIVE BALANCE SHEET DATA Assets +$2.4 B 6% CAGR Loans +$2.3 B 9% CAGR Core Deposits +$1.9 B 8% CAGR NIB Deposits +$653 M 14% CAGR

Loans 66% Investme nts 25% Intangibl es 5% BOLI 2% Other 2% COMPARATIVE BALANCE SHEETS 12/31/11 $7.1 B Loans 74% Investme nts 17% Intangibl es 4% BOLI 2% Other 3% 12/31/16 $9.5 B

CRE 27% MF 12% C&I 19% Resi 28% Consum er 12% [CATEGO RY NAME] [VALUE] CRE 28% MF 20% C&I 23% Resi 17% Consum er 8% [CATEGO RY NAME] [VALUE] COMPARATIVE LOAN COMPOSITION 12/31/16 Commercial: 75% Consumer: 25% 12/31/11 Commercial: 60% Consumer: 40%

NIB 13% IB Core 65% Time 22% NIB 21% IB Core 69% Time 10% COMPARATIVE DEPOSITS 12/31/16 NIB $1.3 B Total Core $5.9 B Total Deposits: $6.6 B 12/31/11 NIB $696 M Total Core $4.0 B Total Deposits: $5.2 B

5-YEAR COMPARATIVE INCOME STATEMENT DATA Revenues +$65 M 5% CAGR Net Interest Income +$43 M 4% CAGR Non-Interest Income +$23 M 11% CAGR Net Income +$30 M 9% CAGR EPS +$0.37 6% CAGR

NIM and IRR 3.49 3.38 3.31 3.30 3.20 3.11 NIM 3.04 3.13 3.23 3.24 3.14 3.05 NIM After Provision 233 151 203 208 145 100 AVG 2/10 Spread ($6,600) ($7,581) ($10,624) ($6,778) ($4,350) ($4,451) NII at Risk +200 bp 2011 2012 2013 2014 2015 2016 -3.05% -3.50% -4.82% -2.74% -1.73% -1.65%

HOW WE MEASURE SUCCESS $1.01 $1.18 $1.23 $1.22 $1.33 $1.38 EPS [CELLRANGE] [CELLRANGE] [CELLRANGE] [CELLRANGE] [CELLRANGE] [CELLRANGE] TBV per share $0.12 $0.13 $0.15 $0.15 $0.17 $0.19 Regular Quarterly Cash Dividend per share 3.6% 3.5% 3.1% 3.4% 3.4% 2.7% Dividend Yield $13.39 $14.92 $19.32 $18.06 $20.15 $28.30 Closing Price 2011 2012 2013 2014 2015 2016 5% CAGR +58% 5-year TSR 155% 6% CAGR

Investor Roadshow March 28 thru March 31, 2017